Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by FredTheVoiceon Mar 07, 2018 8:39am

160 Views

Post# 27674097

For new investors; wondering...

If you just arrived on the board, and you are exited by the movement......please read guys like SPCEO, and lots of other folks......but read posts last week; go back last month; go back last year. Read the exchange between those guys. You will have all the answer about how much, and how good this thing is, ... a long and very good investment place to be for 2018-2019 and more.

Make your DD. But dont read only about yesterdays celebration and the PEEL PUB night in montreal.

Go back......just a little bit. You will want to stay with us for a long time, ...and great ride to come in the next two years.

Good day.

FTV.

Bullboard Posts

Options trading in a volatile macro environment